Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
01/2004
01/13/2004US6677335 Pharmaceutically active compounds
01/13/2004US6677110 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound
01/13/2004US6676976 Process for the production of vasicine
01/08/2004WO2004002991A1 Porphyrin-polyamine conjugates for cancer therapy
01/08/2004WO2004002986A2 Novel benzimidazole derivatives
01/08/2004WO2004002964A1 Diaminopyrimidinecarboxa mide derivative
01/08/2004WO2004002960A1 Substituted quinoline ccr5 receptor antagonists
01/08/2004WO2004002406A2 Bicyclic pyrimidinones as coagulation cascade inhibitors
01/08/2004WO2004002405A2 Amino-bicyclic pyrazinones and pyridinones
01/08/2004WO2003090912A9 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
01/08/2004WO2003086315A3 Tyrosine kinase inhibitors
01/08/2004WO2003080614A3 Triazolopyrimidines used as fungicides
01/08/2004WO2003061604A3 Novel alkyl/aryl hydroxy or keto thiepines.
01/08/2004WO2003055856A3 BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
01/08/2004WO2003028628A3 Photosensitizing carbamate derivatives
01/08/2004US20040006238 As chemical intermediates for production of pharmacologically useful oxazolidinones
01/08/2004US20040006236 Diaminopropionic acid derivatives
01/08/2004US20040006101 Quinolinone derivatives
01/08/2004US20040006096 Substituted alkanohydroxamic acids and method of reducing TNFalpha levels
01/08/2004US20040006083 Pyrazolopyrimidines as therapeutic agents
01/08/2004US20040006080 Chemical compounds
01/08/2004US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease
01/08/2004US20040006066 Ring fused pyrazole derivatives as CRF antagonists
01/08/2004US20040006065 Bicyclic pyrimidinones as coagulation cascade inhibitors
01/08/2004US20040006064 For therapy of cancers, leukemias, parasites and as reversal agents of harringtonines
01/08/2004US20040006063 Dipeptide derivatives
01/08/2004US20040006054 Cytotoxic N-unsubstituted indoles and cyclopent(b)indoles and method of making and using same
01/08/2004US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer
01/08/2004DE19501377B4 Verfahren zur Herstellung von trans-1,4,5,8-Tetranitro-1,4,5,8-tetraazadecalin (TNAD) The method for producing trans-1,4,5,8-tetranitro-1,4,5,8-tetraazadecalin (tNAD)
01/08/2004DE10327492A1 Optisches Verfahren zum Messen der Sauerstoffkonzentration und optischer Sensor zum Messen der Sauerstoffkonzentration An optical method for measuring the oxygen concentration and optical sensor for measuring the oxygen concentration
01/08/2004DE10227507A1 Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Cationically substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use
01/08/2004DE10227506A1 Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Ring-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use
01/08/2004DE10226943A1 Phenylaminopyrimidine und ihre Verwendung Phenylaminopyrimidine and their use
01/08/2004CA2490298A1 Porphyrin-polyamine conjugates for cancer therapy
01/08/2004CA2489560A1 Substituted quinoline ccr5 receptor antagonists
01/07/2004EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor
01/07/2004EP1378511A1 Process for the continous preparation of Acetylenediureine
01/07/2004EP1378267A1 Use of flumazenil to produce a medicament for the treatment of cocaine dependency
01/07/2004EP1378246A1 Remedies for arteriosclerosis
01/07/2004EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
01/07/2004EP1377586A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists
01/07/2004EP1377585A1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
01/07/2004EP1377584A1 Novel cyclohexenyl phenyl diazepines as vasopressin and oxytocin receptor modulators
01/07/2004EP1377583A1 Novel tricyclic hydroxy carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
01/07/2004EP1377582A1 Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists
01/07/2004EP1377581A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof as tocolytic oxytocin receptor antagonists
01/07/2004EP1377580A2 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
01/07/2004EP1377577A1 Pyrrole derivates for treating cytokine mediated diseases
01/07/2004EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
01/07/2004EP1377556A1 Pyrazole derivatives for treating hiv
01/07/2004EP1377549A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
01/07/2004EP1377296A2 Antiviral method of use
01/07/2004EP1377220A1 Fluorescent cobalamins and uses thereof
01/07/2004CN1465576A Preparation for C60 polyazepine derivative
01/06/2004US6673940 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
01/06/2004US6673927 Farnesyl transferase inhibitors
01/06/2004US6673924 1,2,4-triazolol[4,3-a][1,3,5]triazine-3,5,7-substituted precursor, and process, and compounds therefrom
01/06/2004US6673825 Urazole compounds useful as anti-inflammatory agents
01/06/2004US6673810 Anticoagulants
01/06/2004US6673802 Cardiovascular disorders; central nervous system disorders
01/06/2004US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
01/06/2004US6673797 Cyclooxygenase-2 inhibitors; treating inflammatory disease induced by cyclooxygenase-2
01/06/2004CA2093630C Pyrroloazepine compound
01/02/2004EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
01/02/2004EP1375482A1 Benzamidine derivative
01/02/2004EP1374952A1 Use of flumazenil in developing a drug for the treatment of alcohol dependence
01/02/2004EP1374897A1 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates
01/02/2004EP1373274A1 A process for synthesis of a porphyrin compound using a molecular sieve catalyst under microwave irradiation
01/02/2004EP1373272A2 Tert. alkylphenoxy substituted polycyclic compounds
01/02/2004EP1373270A1 Tricyclic quinoxaline derivatives as a uv filter
01/02/2004EP1373269A1 Jun kinase inhibitors
01/02/2004EP1373268A2 Method for the manufacture of anagrelide
01/02/2004EP1373251A2 Non-imidazole compounds as histamine h3 antagonists
01/02/2004EP1373247A2 Spiroisoquinoline compounds, methods for their preparation and intermediates thereof
01/02/2004EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2004EP1373224A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
01/02/2004EP1373222A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
01/02/2004EP1372656A1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors
01/02/2004EP1372655A2 Cathepsin cysteine protease inhibitors
01/02/2004EP1372620A2 Methods for restoring cognitive function following systemic stress
01/02/2004EP1235830B1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS
01/02/2004EP0976753B1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES
01/01/2004US20040002607 Sharp images; color photography
01/01/2004US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound
01/01/2004US20040002528 CBI analogs of CC-1065 and the duocarmycins
01/01/2004US20040002513 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
01/01/2004US20040002496 Compositions useful as inhibitors of protein kinases
01/01/2004US20040002123 Detection of transmembrane potentials by optical methods
12/2003
12/31/2003WO2004000845A1 Arylalkyl indoles having sertonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
12/31/2003WO2004000844A1 Pyrazolopyrimidines and the use thereof for controlling harmful organisms
12/31/2003WO2004000843A1 NOVEL PURINE- OR PYRROLOL[2,3-d]PYRIMIDINE-2-CARBONITILES FOR TREATING DISEASES ASSOCIATED WITH CYSTEINE PROTEASE ACTIVITY
12/31/2003WO2004000841A1 Hetero-bicyclic compounds
12/31/2003WO2004000840A2 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003WO2004000832A1 1-[(indol-3-yl)carbonyl] piperazine derivatives
12/31/2003WO2004000819A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives
12/31/2003WO2004000804A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003WO2004000803A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
12/31/2003WO2004000802A2 Scaffolded maleimide clusters for multivalent peptide assembly
12/31/2003WO2004000800A2 Electrochromic salts, solutions, and devices
12/31/2003WO2004000308A1 Method of photodynamic diagnosis for vascular diseases